Master in Vaccinology and Pharmaceutical Clinical Development

10-10-12

Aditec partner Novartis Vaccines Institute for Global Health (NVGH) organizes, together with University of Siena and Novartis Vaccines Academy, the 3rd Master in Vaccinology and Pharmaceutical Clinical Development in Siena Italy

The Master is an eighteen month training programme aimed to prepare students for a career in academia, public health and research & development in public and private vaccine institutes. It combines theoretical and practical training in immunology, infectious diseases, clinical development methodology and vaccinology, from research to licensure. The training is given by worldwide vaccine experts from academia, supranational organizations (e.g. WHO, EMA, Sabin Institute, Gates Foundation) and Industry.

The master course is conducted in English and is composed by:

  • A one year course which includes ten teaching modules on all relevant disciplines of vaccinology and clinical development and practical trainings at the University Hospital of Siena;
  • A 6-month internship within Novartis clinical development departments or at the University of Surrey Clinical Research Centre, or at another ADITEC partner organization clinical development department

At the end of the Master, following submission and discussion of a thesis, the students will receive a second level Master certificate from the University of Siena.

Aditec sponsors participation of six students to the Master. Candidates must be:

  • Currently working in a European Union or Associated Member state or
  • Currently working in a vaccine development project funded by the European Commission or EDCTP.

Application deadline: February 5th, 2013.

More information can be found here.